madman
Super Moderator
Urologists discuss innovative BPH treatments, emphasizing personalized care, and the importance of ejaculatory preservation.
www.urologytimes.com
In this episode of Pearls & Perspectives, host Amy Pearlman, MD, is joined by Kevin Zorn, MD, at the American Urological Association meeting in Las Vegas. They dive into the evolving landscape of benign prostatic hyperplasia (BPH) treatment—covering everything from personalized care in private practice to research collaborations that stretch far beyond traditional academic walls.
Zorn shares his journey from academia to opening BPH Canada, a center focused on comprehensive, individualized care for men dealing with prostate issues. He explains how moving out of an academic setting has actually allowed him to do more research, not less—thanks to flexible structures, external IRBs, and strong collaborations through groups like ICARUS.
They talk about the rapid expansion of BPH technologies and how Zorn’s approach is to offer the full range—not just what’s convenient or available in one setting. “No man should feel steered into a treatment because it’s the only one on the shelf,” he says. From UroLift to Aquablation and beyond, he outlines how shared decision-making is only meaningful when patients truly have options.
Zorn also previews his plenary talk on ejaculatory preservation, calling it a critical piece of informed consent that’s too often brushed aside. They cover what techniques can help preserve function, how to talk to patients about it, and why it’s time to ditch the “less mess” joke.
They close by discussing a supplement aimed at ejaculatory volume, real patient conversations about sex and expectations, and why old questionnaires might not capture the full story. For Zorn, it all comes back to one thing: treating patients like people, not procedures.
Pearls & Perspectives: Expanding BPH care & patient choice, with Kevin Zorn, MD, at AUA 25
Urologists discuss innovative BPH treatments, emphasizing personalized care, and the importance of ejaculatory preservation.
In this episode of Pearls & Perspectives, host Amy Pearlman, MD, is joined by Kevin Zorn, MD, at the American Urological Association meeting in Las Vegas. They dive into the evolving landscape of benign prostatic hyperplasia (BPH) treatment—covering everything from personalized care in private practice to research collaborations that stretch far beyond traditional academic walls.
Zorn shares his journey from academia to opening BPH Canada, a center focused on comprehensive, individualized care for men dealing with prostate issues. He explains how moving out of an academic setting has actually allowed him to do more research, not less—thanks to flexible structures, external IRBs, and strong collaborations through groups like ICARUS.
They talk about the rapid expansion of BPH technologies and how Zorn’s approach is to offer the full range—not just what’s convenient or available in one setting. “No man should feel steered into a treatment because it’s the only one on the shelf,” he says. From UroLift to Aquablation and beyond, he outlines how shared decision-making is only meaningful when patients truly have options.
Zorn also previews his plenary talk on ejaculatory preservation, calling it a critical piece of informed consent that’s too often brushed aside. They cover what techniques can help preserve function, how to talk to patients about it, and why it’s time to ditch the “less mess” joke.
They close by discussing a supplement aimed at ejaculatory volume, real patient conversations about sex and expectations, and why old questionnaires might not capture the full story. For Zorn, it all comes back to one thing: treating patients like people, not procedures.
